Navigation Links
Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf
Date:5/23/2013

CAMBRIDGE, England, May 24, 2013 /PRNewswire/ --

Die Übersetzungen wurden von PRNewswire und nicht von Mundipharma angefertigt – Bei der englischen Version handelt es sich um die endgültige Version

  • 91 % der Teilnehmer einer groß angelegten Asthmaumfrage halten ihren Zustand für gut kontrolliert, obwohl nur 20 % laut GINA[*]-Definition[1] als kontrolliert gelten können
  • Die Umfrage zeigt, dass Menschen mit Asthma generell einer von vier Denkweisen zugeordnet werden können, die alle von einem angepassten Krankheitsmanagement profitieren könnten

Die heute bei der wissenschaftlichen Tagung der International Primary Care Respiratory Group (IPCRG) in Schweden präsentierten Daten lassen eine deutliche Diskrepanz zwischen der Asthmakontrolle, wie sie der Patient sieht und wie sie in Richtlinien definiert ist, in Europa erkennen.[1] Die Resultate einer großen paneuropäischen Asthmaumfrage, die in einer Partnerschaft von Mundipharma International und Asthmaexperten durchgeführt wurde, zeigen, dass Patienten auftretende Symptome nicht mit schlechter Asthmakontrolle gleichsetzen, weil sie oft nicht realisieren, dass ihr Asthma besser versorgt werden kann.[1] Die Ergebnisse legen außerdem nahe, dass die Erfahrungen mit Asthma und die Einstellungen zur Krankheit variieren, und dass das Verständnis dieser Einstellungen ein Schlüssel zu besserem Asthmamanagement und günstigerem Krankheitsverlauf sein kann.

Die REALISE- Umfrage (REcognise Asthma and LInk to Symptoms and Experience) unter 8000 Menschen mit Asthma im Alter von 18-50 Jahren in 11 Ländern[1] bestätigt, dass suboptimale Asthmaversorgun
'/>"/>

SOURCE Mundipharma
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Neue Studien beweisen die tödliche Verbindung zwischen Alkohol, Gewicht und Lebererkrankungen bei Frauen
2. Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain
3. Blutkrankheiten: Zehntausend europäische Hämatologen versammeln sich vom13.-16. Juni 2013 in Stockholm
4. Researchers untangle molecular pathology of giant axonal neuropathy
5. Blutkrankheiten: Europäische Hämatologen kommen vom 13. bis zum 16. Juni 2013 in Stockholm zusammen
6. Stemedica Issued U.S. Patent For Stem Cell Treatment of Diabetic Retinopathy and Diabetic Optic Neuropathy
7. Convergence Pharmaceuticals Announces Successful Completion of Phase I for CNV2197944 and Plans Phase II Studies in Neuropathic Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... 14, 2014 EquitiesIQ, a leading informational ... ALQA). Alliqua is an emerging biomedical company acquiring, developing, ... care market. , Free report download: http://equitiesiq.com/reports/alliqua/ ... seasoned management team and Board, which launched the company’s ...
(Date:1/14/2014)... BETHESDA, Md. , Jan. 14, 2014  Organovo ... institutes from the National Institutes of Health (NIH) to ... more effective treatments to patients on a faster timeline. ... Translational Sciences (NCATS) and the National Eye Institute (NEI) ...
(Date:1/14/2014)... 2014 In recent years, growing suspicion ... in product development and promotion has led to unprecedented ... fueled by concerns about the insidious impact of commercialization ... spectacular fines to the world’s biggest pharmas for illegal ...
(Date:1/14/2014)... Rockville, MD (PRWEB) January 14, 2014 ... dedicated to developing innovative information technology solutions for ... other health care stakeholders, announced today the signing ... the US Food and Drug Administration (FDA). ...
Breaking Biology Technology:EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3Global Record Systems Announces Research Collaboration Agreement with FDA to Create a Novel “Big Data” Paradigm for Collection of Patient Safety and Outcomes Information 2
... pace of growing computing power could be sustained for ... from the UK,s National Physical Laboratory (NPL) that is ... observed that the density of transistors on an integrated ... time to achieve this, but experts believed that when ...
... OMAHA, Neb., Dec. 9 Transgenomic, Inc.,(OTC Bulletin ... been,awarded an accreditation by the Commission on Laboratory ... on the results of a recent,on-site inspection. Transgenomic ... laboratories nationwide. , Craig Tuttle, CEO ...
... Kingdom and MONTREAL, Dec. 9 /PRNewswire-FirstCall/ - ProMetic ... U.K.-based subsidiary, ProMetic BioSciences Ltd ("PBL"), has signed ... world-leading European Biopharmaceutical company estimated to be worth ... years, with first shipment delivery starting this quarter. ...
Cached Biology Technology:Transgenomic Receives Accreditation From College of American Pathologists 2Transgenomic Receives Accreditation From College of American Pathologists 3ProMetic signs $35 M Long-term Supply Agreement with European Biopharmaceutical company 2ProMetic signs $35 M Long-term Supply Agreement with European Biopharmaceutical company 3
(Date:4/24/2014)... State University and the University of North Carolina at ... could help identify arterial plaque that is at high ... stroke. , At issue is the plaque that builds ... plaque are deemed "vulnerable," meaning that they are more ... heart attack or stroke. , "Existing state-of-the-art technologies are ...
(Date:4/24/2014)... RICHLAND, Wash. A common plant puts out a welcome ... the mat,s molecular mix. , The study published this week ... reveals new targets during the battle between microbe and ... team showed that the humble and oft-studied plant Arabidopsis ... from a pathogen. It,s as if a hostile army were ...
(Date:4/23/2014)... German . Man ... difference between sexes depends on one single element of the genome: ... two sexual chromosomes are X and Y, whereas women have two ... morphological and physiological differences between males and females. , But this ... the X and Y were identical, until the Y started to ...
Breaking Biology News(10 mins):New ultrasound device may add in detecting risk for heart attack, stroke 2How a plant beckons the bacteria that will do it harm 2How a plant beckons the bacteria that will do it harm 3Male or female? 2Male or female? 3
... the diet for Thanksgiving? Turkey with all the fixings ... their goals, according to a new Cornell University review ... willpower every day. "We,re slaves to our environment," ... psychology at Cornell, who co-authored the article with graduate ...
... WASHINGTON, Nov. 16, 2011 A new episode ... Challenges/Chemistry Solutions" podcast series spins a real-life tale ... major barrier to the use of gene therapy in ... largest scientific society explains in non-technical language that gene ...
... DURHAM, New Hampshire, November 16, 2011 A study ... Thursday, Nov. 17, concludes that forests influence temperature, and ... Hollinger, a plant physiologist with the U.S. Forest Service,s ... Xuhui Lee, a professor of meteorology at the Yale ...
Cached Biology News:New American Chemical Society podcast: Genetically-engineered spider silk for gene therapy 2Forests cooler or warmer than open areas depending on latitude, study finds 2